Centre Hospitalier Departemental Vendee

The center is at the forefront of cardiovascular medicine, focusing on innovative treatments for acute myocardial infarction. The AMUNDSEN-real trial exemplifies our commitment to advancing therapeutic strategies, particularly in the use of evolocumab to achieve significant LDL-C reduction.

• Acute Myocardial Infarction
• LDL-C Management
• Innovative Lipid-Lowering Therapies

Our research contributes to the development of personalized treatment plans that enhance patient outcomes in real-world settings.

Our center excels in respiratory medicine, with a particular emphasis on Chronic Pulmonary Aspergillosis. Through trials like CPAAARI, we explore the efficacy of combined antifungal therapies, enhancing treatment protocols for non-immunocompromised patients.

• Chronic Pulmonary Aspergillosis
• Antifungal Therapy
• Respiratory Infections

Our work aims to refine therapeutic approaches, improving both clinical and radiological outcomes for patients.

In the field of oncology, our center is pioneering research in multiple myeloma and other hematological malignancies. The IFM2020-05-BENEFIT study highlights our efforts in evaluating novel drug combinations to improve Minimal Residual Disease rates.

• Multiple Myeloma
• Hematological Malignancies
• Novel Drug Combinations

Our research is instrumental in developing targeted therapies that offer hope for better management of these complex conditions.

Our center is advancing the field of endocrinology through studies like the post-thyroidectomy hypocalcemia trial, which investigates the role of cholecalciferol supplementation in preventing complications after thyroid surgery.

• Thyroid Disorders
• Postoperative Care
• Vitamin D Supplementation

We aim to enhance surgical outcomes and patient comfort through innovative preoperative strategies.

In rheumatology, our center is exploring advanced treatment options for rheumatoid arthritis. Trials like the combination of methotrexate with targeted therapies are pivotal in improving patient response and quality of life.

• Rheumatoid Arthritis
• Targeted Therapies
• Combination Treatments

Our research is dedicated to finding more effective and personalized treatment regimens for chronic inflammatory conditions.

Our center is a leader in nephrology, focusing on innovative treatments for renal cell carcinoma and other kidney-related conditions. Studies comparing tivozanib combinations are crucial in enhancing therapeutic efficacy.

• Renal Cell Carcinoma
• Kidney Health
• Targeted Cancer Therapies

We strive to improve survival rates and quality of life for patients with advanced kidney diseases.